Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysis

Umbleja T, Zafar MU, McCallum S, Gattu AK, Zanni MV, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Currier JS, Sponseller CA, Diggs MR, Chu SM, Lu[...]

Trends and Disparities in Aortic Stenosis and Coronary Artery Disease-Related Mortality Among U.S. Adults Aged ≥65 Years, 1999-2024

Daniyal SM, Sarwar M, Fahim SL, Khatoon NM, Noor A, Batool F, Riaz M, Ajaz H, Gondal HT, Aftab Z, Gul I, Fonarow GC. Trends[...]

Comparison of Inpatient End-of-Life Care Intensity Between Heart Failure and Cancer

Halloran S, Meng Z, Harap R, Baldridge A, Wilcox J, Rao A, Adaboh A, Fonarow GC, Allen LA, Tibrewala A, Chuzi S. Comparison of Inpatient[...]